115 related articles for article (PubMed ID: 10202833)
1. AIDS diagnoses at higher CD4 counts in Australia following the introduction of highly active antiretroviral treatment.
Law MG; de Winter L; McDonald A; Cooper DA; Kaldor JM
AIDS; 1999 Feb; 13(2):263-9. PubMed ID: 10202833
[TBL] [Abstract][Full Text] [Related]
2. Ten-year trends in CD4 cell counts at HIV and AIDS diagnosis in a London HIV clinic.
Easterbrook PJ; Yu LM; Goetghebeur E; Boag F; McLean K; Gazzard B
AIDS; 2000 Mar; 14(5):561-71. PubMed ID: 10780719
[TBL] [Abstract][Full Text] [Related]
3. Discontinuation of prophylaxis for Pneumocystis carinii pneumonia in HIV-1-infected patients treated with highly active antiretroviral therapy.
Schneider MM; Borleffs JC; Stolk RP; Jaspers CA; Hoepelman AI
Lancet; 1999 Jan; 353(9148):201-3. PubMed ID: 9923876
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
Jacobson MA; Zegans M; Pavan PR; O'Donnell JJ; Sattler F; Rao N; Owens S; Pollard R
Lancet; 1997 May; 349(9063):1443-5. PubMed ID: 9164318
[TBL] [Abstract][Full Text] [Related]
5. Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group.
Weverling GJ; Mocroft A; Ledergerber B; Kirk O; Gonzáles-Lahoz J; d'Arminio Monforte A; Proenca R; Phillips AN; Lundgren JD; Reiss P
Lancet; 1999 Apr; 353(9161):1293-8. PubMed ID: 10218526
[TBL] [Abstract][Full Text] [Related]
6. The incidence of AIDS-defining illnesses in 4883 patients with human immunodeficiency virus infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group.
Mocroft A; Youle M; Phillips AN; Halai R; Easterbrook P; Johnson MA; Gazzard B
Arch Intern Med; 1998 Mar; 158(5):491-7. PubMed ID: 9508227
[TBL] [Abstract][Full Text] [Related]
7. Setting a minimum threshold CD4 count for initiation of highly active antiretroviral therapy in HIV-infected patients.
Ho C; Lee S; Wong Kh; Cheng L; Lam M
HIV Med; 2007 Apr; 8(3):181-5. PubMed ID: 17461862
[TBL] [Abstract][Full Text] [Related]
8. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
Wong KH; Chan KC; Lee SS
Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
[TBL] [Abstract][Full Text] [Related]
9. The role of initial AIDS-defining illness in survival following AIDS.
Luo K; Law M; Kaldor JM; McDonald AM; Cooper DA
AIDS; 1995 Jan; 9(1):57-63. PubMed ID: 7893442
[TBL] [Abstract][Full Text] [Related]
10. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
Bonnet F; Thiébaut R; Chêne G; Neau D; Pellegrin JL; Mercié P; Beylot J; Dabis F; Salamon R; Morlat P;
HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287
[TBL] [Abstract][Full Text] [Related]
11. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
Ives NJ; Gazzard BG; Easterbrook PJ
J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
[TBL] [Abstract][Full Text] [Related]
12. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy.
Hogg RS; Yip B; Chan KJ; Wood E; Craib KJ; O'Shaughnessy MV; Montaner JS
JAMA; 2001 Nov; 286(20):2568-77. PubMed ID: 11722271
[TBL] [Abstract][Full Text] [Related]
13. Increasing survival time after AIDS in Italy: the role of new combination antiretroviral therapies. Tuscany AIDS Study Group.
Pezzotti P; Napoli PA; Acciai S; Boros S; Urciuoli R; Lazzeri V; Rezza G
AIDS; 1999 Feb; 13(2):249-55. PubMed ID: 10202831
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of the five-year effectiveness of highly active antiretroviral therapy among 200 HIV/AIDS patients in Jiangsu province].
Qiu T; Ding P; Liu X; Guo H; Fu G; Xu X; Huan X; Yang H
Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Nov; 48(11):947-52. PubMed ID: 25582363
[TBL] [Abstract][Full Text] [Related]
15. CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection.
Baker JV; Peng G; Rapkin J; Abrams DI; Silverberg MJ; MacArthur RD; Cavert WP; Henry WK; Neaton JD;
AIDS; 2008 Apr; 22(7):841-8. PubMed ID: 18427202
[TBL] [Abstract][Full Text] [Related]
16. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy.
Dore GJ; Correll PK; Li Y; Kaldor JM; Cooper DA; Brew BJ
AIDS; 1999 Jul; 13(10):1249-53. PubMed ID: 10416530
[TBL] [Abstract][Full Text] [Related]
17. Improving survival following AIDS in Australia, 1991-1996. National HIV Surveillance Committee.
Li Y; McDonald AM; Dore GJ; Kaldor JM
AIDS; 2000 Oct; 14(15):2349-54. PubMed ID: 11089623
[TBL] [Abstract][Full Text] [Related]
18. Association between Highly Active Antiretroviral Therapy and Type of Infectious Respiratory Disease and All-Cause In-Hospital Mortality in Patients with HIV/AIDS: A Case Series.
Báez-Saldaña R; Villafuerte-García A; Cruz-Hervert P; Delgado-Sánchez G; Ferreyra-Reyes L; Ferreira-Guerrero E; Mongua-Rodríguez N; Montero-Campos R; Melchor-Romero A; García-García L
PLoS One; 2015; 10(9):e0138115. PubMed ID: 26379281
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the effectiveness of highly active antiretroviral therapy in persons with human immunodeficiency virus using biomarker-based equivalence of disease progression.
Jacobson LP; Li R; Phair J; Margolick JB; Rinaldo CR; Detels R; Muñoz A
Am J Epidemiol; 2002 Apr; 155(8):760-70. PubMed ID: 11943695
[TBL] [Abstract][Full Text] [Related]
20. CD4 cell counts in adults with newly diagnosed HIV infection in Barbados.
Kilaru KR; Kumar A; Sippy N
Rev Panam Salud Publica; 2004 Nov; 16(5):302-7. PubMed ID: 15729978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
